Global Single-Use Technology for Biopharmaceuticals Supply, Demand and Key Producers, 2026-2032
The global Single-Use Technology for Biopharmaceuticals market size is expected to reach $ 11118 million by 2032, rising at a market growth of 9.7% CAGR during the forecast period (2026-2032).
Single-Use Technology for Biopharmaceuticals refers to disposable bioprocessing systems, components, and consumables used in the development and manufacturing of biopharmaceutical products. These technologies are designed to be used for a single production batch, process step, or manufacturing campaign and then discarded, replacing traditional stainless-steel systems that require cleaning, sterilization, and validation.
In the biopharmaceutical industry, single-use technology typically includes single-use bioreactors, media and buffer bags, storage bags, mixing systems, tubing assemblies, sterile connectors, filters, sampling systems, sensors, and fill-finish assemblies. These products are widely used in upstream processing, downstream processing, fluid management, formulation, and aseptic transfer for the production of monoclonal antibodies, vaccines, recombinant proteins, cell therapies, gene therapies, mRNA products, and other biologics.
The single-use technology for biopharmaceutical sector is characterized by high gross margins; leading international companies maintain gross margins exceeding 50% thanks to technological barriers and brand advantages.
Single-use technology in biopharmaceuticals is rapidly evolving toward greater intelligence, modularity, and sustainability. Future trends include ?smart single-use systems??integrating sensors and IoT technology?to enable real-time process monitoring and digital control; modular facility designs that shorten construction timelines and enhance production flexibility; and customized single-use solutions tailored for emerging therapies such as mRNA and cell and gene therapies. Regarding sustainability, the industry is shifting from traditional plastics to bio-based, biodegradable materials while simultaneously reducing waste through closed-loop recycling systems.
In terms of raw materials, multi-layer co-extruded films (e.g., polyethylene, EVOH barrier layers), silicone tubing, and thermoplastic elastomers (TPE) remain dominant; however, the supply chain is undergoing profound transformation. There is a heavy reliance on a limited number of European and American suppliers (such as Thermo Fisher, Sartorius, and Merck) for key resins and films, though geopolitical factors and the post-pandemic landscape are driving a diversification of global production capacity. Chinese enterprises are accelerating efforts to achieve import substitution for high-end films and precision connectors. Furthermore, increasingly stringent standards for extractables and leachables (E&L) are pushing raw materials toward higher purity, lower adsorption, and reduced particle shedding, with biocompatibility certifications (e.g., USP Class VI, ISO 10993) becoming essential market entry requirements.
This report studies the global Single-Use Technology for Biopharmaceuticals demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Single-Use Technology for Biopharmaceuticals, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Single-Use Technology for Biopharmaceuticals that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Single-Use Technology for Biopharmaceuticals total market, 2021-2032, (USD Million)
Global Single-Use Technology for Biopharmaceuticals total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Single-Use Technology for Biopharmaceuticals total market, key domestic companies, and share, (USD Million)
Global Single-Use Technology for Biopharmaceuticals revenue by player, revenue and market share 2021-2026, (USD Million)
Global Single-Use Technology for Biopharmaceuticals total market by Type, CAGR, 2021-2032, (USD Million)
Global Single-Use Technology for Biopharmaceuticals total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Single-Use Technology for Biopharmaceuticals market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Danaher (US), Sartorius (DE), Thermo Fisher Scientific (US), Merck KGaA (DE), Repligen (US), Meissner Filtration Products (US), ABEC (US), Avantor (US), Corning (US), Entegris (US), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Single-Use Technology for Biopharmaceuticals market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Single-Use Technology for Biopharmaceuticals Market, By Region:
1. How big is the global Single-Use Technology for Biopharmaceuticals market?
2. What is the demand of the global Single-Use Technology for Biopharmaceuticals market?
3. What is the year over year growth of the global Single-Use Technology for Biopharmaceuticals market?
4. What is the total value of the global Single-Use Technology for Biopharmaceuticals market?
5. Who are the Major Players in the global Single-Use Technology for Biopharmaceuticals market?
6. What are the growth factors driving the market demand?
Single-Use Technology for Biopharmaceuticals refers to disposable bioprocessing systems, components, and consumables used in the development and manufacturing of biopharmaceutical products. These technologies are designed to be used for a single production batch, process step, or manufacturing campaign and then discarded, replacing traditional stainless-steel systems that require cleaning, sterilization, and validation.
In the biopharmaceutical industry, single-use technology typically includes single-use bioreactors, media and buffer bags, storage bags, mixing systems, tubing assemblies, sterile connectors, filters, sampling systems, sensors, and fill-finish assemblies. These products are widely used in upstream processing, downstream processing, fluid management, formulation, and aseptic transfer for the production of monoclonal antibodies, vaccines, recombinant proteins, cell therapies, gene therapies, mRNA products, and other biologics.
The single-use technology for biopharmaceutical sector is characterized by high gross margins; leading international companies maintain gross margins exceeding 50% thanks to technological barriers and brand advantages.
Single-use technology in biopharmaceuticals is rapidly evolving toward greater intelligence, modularity, and sustainability. Future trends include ?smart single-use systems??integrating sensors and IoT technology?to enable real-time process monitoring and digital control; modular facility designs that shorten construction timelines and enhance production flexibility; and customized single-use solutions tailored for emerging therapies such as mRNA and cell and gene therapies. Regarding sustainability, the industry is shifting from traditional plastics to bio-based, biodegradable materials while simultaneously reducing waste through closed-loop recycling systems.
In terms of raw materials, multi-layer co-extruded films (e.g., polyethylene, EVOH barrier layers), silicone tubing, and thermoplastic elastomers (TPE) remain dominant; however, the supply chain is undergoing profound transformation. There is a heavy reliance on a limited number of European and American suppliers (such as Thermo Fisher, Sartorius, and Merck) for key resins and films, though geopolitical factors and the post-pandemic landscape are driving a diversification of global production capacity. Chinese enterprises are accelerating efforts to achieve import substitution for high-end films and precision connectors. Furthermore, increasingly stringent standards for extractables and leachables (E&L) are pushing raw materials toward higher purity, lower adsorption, and reduced particle shedding, with biocompatibility certifications (e.g., USP Class VI, ISO 10993) becoming essential market entry requirements.
This report studies the global Single-Use Technology for Biopharmaceuticals demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Single-Use Technology for Biopharmaceuticals, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Single-Use Technology for Biopharmaceuticals that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Single-Use Technology for Biopharmaceuticals total market, 2021-2032, (USD Million)
Global Single-Use Technology for Biopharmaceuticals total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Single-Use Technology for Biopharmaceuticals total market, key domestic companies, and share, (USD Million)
Global Single-Use Technology for Biopharmaceuticals revenue by player, revenue and market share 2021-2026, (USD Million)
Global Single-Use Technology for Biopharmaceuticals total market by Type, CAGR, 2021-2032, (USD Million)
Global Single-Use Technology for Biopharmaceuticals total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Single-Use Technology for Biopharmaceuticals market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Danaher (US), Sartorius (DE), Thermo Fisher Scientific (US), Merck KGaA (DE), Repligen (US), Meissner Filtration Products (US), ABEC (US), Avantor (US), Corning (US), Entegris (US), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Single-Use Technology for Biopharmaceuticals market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Single-Use Technology for Biopharmaceuticals Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Single-use Bioreactors
- Single-use Bags & Containers
- Filtration Assemblies
- Tubing & Connectors
- Others
- Biopharmaceutical Companies
- CDMOs / CMOs
- Research Institutes
- Cell & Gene Therapy Companies
- Vaccine Manufacturers
- <50 L
- 50?500 L
- 500?1,000 L
- >1,000 L
- Monoclonal Antibodies
- Vaccines
- Cell & Gene Therapy
- Recombinant Proteins
- Others
- Danaher (US)
- Sartorius (DE)
- Thermo Fisher Scientific (US)
- Merck KGaA (DE)
- Repligen (US)
- Meissner Filtration Products (US)
- ABEC (US)
- Avantor (US)
- Corning (US)
- Entegris (US)
- Saint-Gobain Life Sciences (FR)
- Watson-Marlow / BioPure (GB)
- CPC / Colder Products (US)
- Eppendorf (DE)
- Getinge / Applikon (SE)
- PBS Biotech (US)
- Shanghai Tofflon Science and Technology Co., Ltd. (CN)
- Shanghai LePure Biotech Co., Ltd. (CN)
- Shanghai Duoning Biotechnology Co., Ltd. (CN)
1. How big is the global Single-Use Technology for Biopharmaceuticals market?
2. What is the demand of the global Single-Use Technology for Biopharmaceuticals market?
3. What is the year over year growth of the global Single-Use Technology for Biopharmaceuticals market?
4. What is the total value of the global Single-Use Technology for Biopharmaceuticals market?
5. Who are the Major Players in the global Single-Use Technology for Biopharmaceuticals market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Single-Use Technology for Biopharmaceuticals Introduction
1.2 World Single-Use Technology for Biopharmaceuticals Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Single-Use Technology for Biopharmaceuticals Total Market by Region (by Headquarter Location)
1.3.1 World Single-Use Technology for Biopharmaceuticals Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Single-Use Technology for Biopharmaceuticals Revenue (2021-2032)
1.3.3 China Based Company Single-Use Technology for Biopharmaceuticals Revenue (2021-2032)
1.3.4 Europe Based Company Single-Use Technology for Biopharmaceuticals Revenue (2021-2032)
1.3.5 Japan Based Company Single-Use Technology for Biopharmaceuticals Revenue (2021-2032)
1.3.6 South Korea Based Company Single-Use Technology for Biopharmaceuticals Revenue (2021-2032)
1.3.7 ASEAN Based Company Single-Use Technology for Biopharmaceuticals Revenue (2021-2032)
1.3.8 India Based Company Single-Use Technology for Biopharmaceuticals Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Single-Use Technology for Biopharmaceuticals Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032)
2.2 World Single-Use Technology for Biopharmaceuticals Consumption Value by Region
2.2.1 World Single-Use Technology for Biopharmaceuticals Consumption Value by Region (2021-2026)
2.2.2 World Single-Use Technology for Biopharmaceuticals Consumption Value Forecast by Region (2027-2032)
2.3 United States Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032)
2.4 China Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032)
2.5 Europe Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032)
2.6 Japan Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032)
2.7 South Korea Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032)
2.8 ASEAN Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032)
2.9 India Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032)
3 WORLD SINGLE-USE TECHNOLOGY FOR BIOPHARMACEUTICALS COMPANIES COMPETITIVE ANALYSIS
3.1 World Single-Use Technology for Biopharmaceuticals Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Single-Use Technology for Biopharmaceuticals Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Single-Use Technology for Biopharmaceuticals in 2025
3.2.3 Global Concentration Ratios (CR8) for Single-Use Technology for Biopharmaceuticals in 2025
3.3 Single-Use Technology for Biopharmaceuticals Company Evaluation Quadrant
3.4 Single-Use Technology for Biopharmaceuticals Market: Overall Company Footprint Analysis
3.4.1 Single-Use Technology for Biopharmaceuticals Market: Region Footprint
3.4.2 Single-Use Technology for Biopharmaceuticals Market: Company Product Type Footprint
3.4.3 Single-Use Technology for Biopharmaceuticals Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Single-Use Technology for Biopharmaceuticals Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Single-Use Technology for Biopharmaceuticals Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Single-Use Technology for Biopharmaceuticals Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Single-Use Technology for Biopharmaceuticals Consumption Value Comparison
4.2.1 United States VS China: Single-Use Technology for Biopharmaceuticals Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Single-Use Technology for Biopharmaceuticals Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Single-Use Technology for Biopharmaceuticals Companies and Market Share, 2021-2026
4.3.1 United States Based Single-Use Technology for Biopharmaceuticals Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Single-Use Technology for Biopharmaceuticals Revenue, (2021-2026)
4.4 China Based Companies Single-Use Technology for Biopharmaceuticals Revenue and Market Share, 2021-2026
4.4.1 China Based Single-Use Technology for Biopharmaceuticals Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Single-Use Technology for Biopharmaceuticals Revenue, (2021-2026)
4.5 Rest of World Based Single-Use Technology for Biopharmaceuticals Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Single-Use Technology for Biopharmaceuticals Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Single-Use Technology for Biopharmaceuticals Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Single-Use Technology for Biopharmaceuticals Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Single-use Bioreactors
5.2.2 Single-use Bags & Containers
5.2.3 Filtration Assemblies
5.2.4 Tubing & Connectors
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Single-Use Technology for Biopharmaceuticals Market Size by Type (2021-2026)
5.3.2 World Single-Use Technology for Biopharmaceuticals Market Size by Type (2027-2032)
5.3.3 World Single-Use Technology for Biopharmaceuticals Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY END USER
6.1 World Single-Use Technology for Biopharmaceuticals Market Size Overview by End User: 2021 VS 2025 VS 2032
6.2 Segment Introduction by End User
6.2.1 Biopharmaceutical Companies
6.2.2 CDMOs / CMOs
6.2.3 Research Institutes
6.2.4 Cell & Gene Therapy Companies
6.2.5 Vaccine Manufacturers
6.3 Market Segment by End User
6.3.1 World Single-Use Technology for Biopharmaceuticals Market Size by End User (2021-2026)
6.3.2 World Single-Use Technology for Biopharmaceuticals Market Size by End User (2027-2032)
6.3.3 World Single-Use Technology for Biopharmaceuticals Market Size Market Share by End User (2027-2032)
7 MARKET ANALYSIS BY SCALE OF OPERATION
7.1 World Single-Use Technology for Biopharmaceuticals Market Size Overview by Scale of Operation: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Scale of Operation
7.2.1 <50 L
7.2.2 50?500 L
7.2.3 500?1,000 L
7.2.4 >1,000 L
7.3 Market Segment by Scale of Operation
7.3.1 World Single-Use Technology for Biopharmaceuticals Market Size by Scale of Operation (2021-2026)
7.3.2 World Single-Use Technology for Biopharmaceuticals Market Size by Scale of Operation (2027-2032)
7.3.3 World Single-Use Technology for Biopharmaceuticals Market Size Market Share by Scale of Operation (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Single-Use Technology for Biopharmaceuticals Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Monoclonal Antibodies
8.2.2 Vaccines
8.2.3 Cell & Gene Therapy
8.2.4 Recombinant Proteins
8.2.5 Others
8.3 Market Segment by Application
8.3.1 World Single-Use Technology for Biopharmaceuticals Market Size by Application (2021-2026)
8.3.2 World Single-Use Technology for Biopharmaceuticals Market Size by Application (2027-2032)
8.3.3 World Single-Use Technology for Biopharmaceuticals Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Danaher (US)
9.1.1 Danaher (US) Details
9.1.2 Danaher (US) Major Business
9.1.3 Danaher (US) Single-Use Technology for Biopharmaceuticals Product and Services
9.1.4 Danaher (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Danaher (US) Recent Developments/Updates
9.1.6 Danaher (US) Competitive Strengths & Weaknesses
9.2 Sartorius (DE)
9.2.1 Sartorius (DE) Details
9.2.2 Sartorius (DE) Major Business
9.2.3 Sartorius (DE) Single-Use Technology for Biopharmaceuticals Product and Services
9.2.4 Sartorius (DE) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Sartorius (DE) Recent Developments/Updates
9.2.6 Sartorius (DE) Competitive Strengths & Weaknesses
9.3 Thermo Fisher Scientific (US)
9.3.1 Thermo Fisher Scientific (US) Details
9.3.2 Thermo Fisher Scientific (US) Major Business
9.3.3 Thermo Fisher Scientific (US) Single-Use Technology for Biopharmaceuticals Product and Services
9.3.4 Thermo Fisher Scientific (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Thermo Fisher Scientific (US) Recent Developments/Updates
9.3.6 Thermo Fisher Scientific (US) Competitive Strengths & Weaknesses
9.4 Merck KGaA (DE)
9.4.1 Merck KGaA (DE) Details
9.4.2 Merck KGaA (DE) Major Business
9.4.3 Merck KGaA (DE) Single-Use Technology for Biopharmaceuticals Product and Services
9.4.4 Merck KGaA (DE) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Merck KGaA (DE) Recent Developments/Updates
9.4.6 Merck KGaA (DE) Competitive Strengths & Weaknesses
9.5 Repligen (US)
9.5.1 Repligen (US) Details
9.5.2 Repligen (US) Major Business
9.5.3 Repligen (US) Single-Use Technology for Biopharmaceuticals Product and Services
9.5.4 Repligen (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Repligen (US) Recent Developments/Updates
9.5.6 Repligen (US) Competitive Strengths & Weaknesses
9.6 Meissner Filtration Products (US)
9.6.1 Meissner Filtration Products (US) Details
9.6.2 Meissner Filtration Products (US) Major Business
9.6.3 Meissner Filtration Products (US) Single-Use Technology for Biopharmaceuticals Product and Services
9.6.4 Meissner Filtration Products (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Meissner Filtration Products (US) Recent Developments/Updates
9.6.6 Meissner Filtration Products (US) Competitive Strengths & Weaknesses
9.7 ABEC (US)
9.7.1 ABEC (US) Details
9.7.2 ABEC (US) Major Business
9.7.3 ABEC (US) Single-Use Technology for Biopharmaceuticals Product and Services
9.7.4 ABEC (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 ABEC (US) Recent Developments/Updates
9.7.6 ABEC (US) Competitive Strengths & Weaknesses
9.8 Avantor (US)
9.8.1 Avantor (US) Details
9.8.2 Avantor (US) Major Business
9.8.3 Avantor (US) Single-Use Technology for Biopharmaceuticals Product and Services
9.8.4 Avantor (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Avantor (US) Recent Developments/Updates
9.8.6 Avantor (US) Competitive Strengths & Weaknesses
9.9 Corning (US)
9.9.1 Corning (US) Details
9.9.2 Corning (US) Major Business
9.9.3 Corning (US) Single-Use Technology for Biopharmaceuticals Product and Services
9.9.4 Corning (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Corning (US) Recent Developments/Updates
9.9.6 Corning (US) Competitive Strengths & Weaknesses
9.10 Entegris (US)
9.10.1 Entegris (US) Details
9.10.2 Entegris (US) Major Business
9.10.3 Entegris (US) Single-Use Technology for Biopharmaceuticals Product and Services
9.10.4 Entegris (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Entegris (US) Recent Developments/Updates
9.10.6 Entegris (US) Competitive Strengths & Weaknesses
9.11 Saint-Gobain Life Sciences (FR)
9.11.1 Saint-Gobain Life Sciences (FR) Details
9.11.2 Saint-Gobain Life Sciences (FR) Major Business
9.11.3 Saint-Gobain Life Sciences (FR) Single-Use Technology for Biopharmaceuticals Product and Services
9.11.4 Saint-Gobain Life Sciences (FR) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Saint-Gobain Life Sciences (FR) Recent Developments/Updates
9.11.6 Saint-Gobain Life Sciences (FR) Competitive Strengths & Weaknesses
9.12 Watson-Marlow / BioPure (GB)
9.12.1 Watson-Marlow / BioPure (GB) Details
9.12.2 Watson-Marlow / BioPure (GB) Major Business
9.12.3 Watson-Marlow / BioPure (GB) Single-Use Technology for Biopharmaceuticals Product and Services
9.12.4 Watson-Marlow / BioPure (GB) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Watson-Marlow / BioPure (GB) Recent Developments/Updates
9.12.6 Watson-Marlow / BioPure (GB) Competitive Strengths & Weaknesses
9.13 CPC / Colder Products (US)
9.13.1 CPC / Colder Products (US) Details
9.13.2 CPC / Colder Products (US) Major Business
9.13.3 CPC / Colder Products (US) Single-Use Technology for Biopharmaceuticals Product and Services
9.13.4 CPC / Colder Products (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 CPC / Colder Products (US) Recent Developments/Updates
9.13.6 CPC / Colder Products (US) Competitive Strengths & Weaknesses
9.14 Eppendorf (DE)
9.14.1 Eppendorf (DE) Details
9.14.2 Eppendorf (DE) Major Business
9.14.3 Eppendorf (DE) Single-Use Technology for Biopharmaceuticals Product and Services
9.14.4 Eppendorf (DE) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Eppendorf (DE) Recent Developments/Updates
9.14.6 Eppendorf (DE) Competitive Strengths & Weaknesses
9.15 Getinge / Applikon (SE)
9.15.1 Getinge / Applikon (SE) Details
9.15.2 Getinge / Applikon (SE) Major Business
9.15.3 Getinge / Applikon (SE) Single-Use Technology for Biopharmaceuticals Product and Services
9.15.4 Getinge / Applikon (SE) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Getinge / Applikon (SE) Recent Developments/Updates
9.15.6 Getinge / Applikon (SE) Competitive Strengths & Weaknesses
9.16 PBS Biotech (US)
9.16.1 PBS Biotech (US) Details
9.16.2 PBS Biotech (US) Major Business
9.16.3 PBS Biotech (US) Single-Use Technology for Biopharmaceuticals Product and Services
9.16.4 PBS Biotech (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 PBS Biotech (US) Recent Developments/Updates
9.16.6 PBS Biotech (US) Competitive Strengths & Weaknesses
9.17 Shanghai Tofflon Science and Technology Co., Ltd. (CN)
9.17.1 Shanghai Tofflon Science and Technology Co., Ltd. (CN) Details
9.17.2 Shanghai Tofflon Science and Technology Co., Ltd. (CN) Major Business
9.17.3 Shanghai Tofflon Science and Technology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Product and Services
9.17.4 Shanghai Tofflon Science and Technology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Shanghai Tofflon Science and Technology Co., Ltd. (CN) Recent Developments/Updates
9.17.6 Shanghai Tofflon Science and Technology Co., Ltd. (CN) Competitive Strengths & Weaknesses
9.18 Shanghai LePure Biotech Co., Ltd. (CN)
9.18.1 Shanghai LePure Biotech Co., Ltd. (CN) Details
9.18.2 Shanghai LePure Biotech Co., Ltd. (CN) Major Business
9.18.3 Shanghai LePure Biotech Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Product and Services
9.18.4 Shanghai LePure Biotech Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Shanghai LePure Biotech Co., Ltd. (CN) Recent Developments/Updates
9.18.6 Shanghai LePure Biotech Co., Ltd. (CN) Competitive Strengths & Weaknesses
9.19 Shanghai Duoning Biotechnology Co., Ltd. (CN)
9.19.1 Shanghai Duoning Biotechnology Co., Ltd. (CN) Details
9.19.2 Shanghai Duoning Biotechnology Co., Ltd. (CN) Major Business
9.19.3 Shanghai Duoning Biotechnology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Product and Services
9.19.4 Shanghai Duoning Biotechnology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Shanghai Duoning Biotechnology Co., Ltd. (CN) Recent Developments/Updates
9.19.6 Shanghai Duoning Biotechnology Co., Ltd. (CN) Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Single-Use Technology for Biopharmaceuticals Industry Chain
10.2 Single-Use Technology for Biopharmaceuticals Upstream Analysis
10.3 Single-Use Technology for Biopharmaceuticals Midstream Analysis
10.4 Single-Use Technology for Biopharmaceuticals Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Single-Use Technology for Biopharmaceuticals Introduction
1.2 World Single-Use Technology for Biopharmaceuticals Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Single-Use Technology for Biopharmaceuticals Total Market by Region (by Headquarter Location)
1.3.1 World Single-Use Technology for Biopharmaceuticals Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Single-Use Technology for Biopharmaceuticals Revenue (2021-2032)
1.3.3 China Based Company Single-Use Technology for Biopharmaceuticals Revenue (2021-2032)
1.3.4 Europe Based Company Single-Use Technology for Biopharmaceuticals Revenue (2021-2032)
1.3.5 Japan Based Company Single-Use Technology for Biopharmaceuticals Revenue (2021-2032)
1.3.6 South Korea Based Company Single-Use Technology for Biopharmaceuticals Revenue (2021-2032)
1.3.7 ASEAN Based Company Single-Use Technology for Biopharmaceuticals Revenue (2021-2032)
1.3.8 India Based Company Single-Use Technology for Biopharmaceuticals Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Single-Use Technology for Biopharmaceuticals Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032)
2.2 World Single-Use Technology for Biopharmaceuticals Consumption Value by Region
2.2.1 World Single-Use Technology for Biopharmaceuticals Consumption Value by Region (2021-2026)
2.2.2 World Single-Use Technology for Biopharmaceuticals Consumption Value Forecast by Region (2027-2032)
2.3 United States Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032)
2.4 China Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032)
2.5 Europe Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032)
2.6 Japan Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032)
2.7 South Korea Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032)
2.8 ASEAN Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032)
2.9 India Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032)
3 WORLD SINGLE-USE TECHNOLOGY FOR BIOPHARMACEUTICALS COMPANIES COMPETITIVE ANALYSIS
3.1 World Single-Use Technology for Biopharmaceuticals Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Single-Use Technology for Biopharmaceuticals Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Single-Use Technology for Biopharmaceuticals in 2025
3.2.3 Global Concentration Ratios (CR8) for Single-Use Technology for Biopharmaceuticals in 2025
3.3 Single-Use Technology for Biopharmaceuticals Company Evaluation Quadrant
3.4 Single-Use Technology for Biopharmaceuticals Market: Overall Company Footprint Analysis
3.4.1 Single-Use Technology for Biopharmaceuticals Market: Region Footprint
3.4.2 Single-Use Technology for Biopharmaceuticals Market: Company Product Type Footprint
3.4.3 Single-Use Technology for Biopharmaceuticals Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Single-Use Technology for Biopharmaceuticals Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Single-Use Technology for Biopharmaceuticals Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Single-Use Technology for Biopharmaceuticals Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Single-Use Technology for Biopharmaceuticals Consumption Value Comparison
4.2.1 United States VS China: Single-Use Technology for Biopharmaceuticals Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Single-Use Technology for Biopharmaceuticals Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Single-Use Technology for Biopharmaceuticals Companies and Market Share, 2021-2026
4.3.1 United States Based Single-Use Technology for Biopharmaceuticals Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Single-Use Technology for Biopharmaceuticals Revenue, (2021-2026)
4.4 China Based Companies Single-Use Technology for Biopharmaceuticals Revenue and Market Share, 2021-2026
4.4.1 China Based Single-Use Technology for Biopharmaceuticals Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Single-Use Technology for Biopharmaceuticals Revenue, (2021-2026)
4.5 Rest of World Based Single-Use Technology for Biopharmaceuticals Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Single-Use Technology for Biopharmaceuticals Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Single-Use Technology for Biopharmaceuticals Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Single-Use Technology for Biopharmaceuticals Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Single-use Bioreactors
5.2.2 Single-use Bags & Containers
5.2.3 Filtration Assemblies
5.2.4 Tubing & Connectors
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Single-Use Technology for Biopharmaceuticals Market Size by Type (2021-2026)
5.3.2 World Single-Use Technology for Biopharmaceuticals Market Size by Type (2027-2032)
5.3.3 World Single-Use Technology for Biopharmaceuticals Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY END USER
6.1 World Single-Use Technology for Biopharmaceuticals Market Size Overview by End User: 2021 VS 2025 VS 2032
6.2 Segment Introduction by End User
6.2.1 Biopharmaceutical Companies
6.2.2 CDMOs / CMOs
6.2.3 Research Institutes
6.2.4 Cell & Gene Therapy Companies
6.2.5 Vaccine Manufacturers
6.3 Market Segment by End User
6.3.1 World Single-Use Technology for Biopharmaceuticals Market Size by End User (2021-2026)
6.3.2 World Single-Use Technology for Biopharmaceuticals Market Size by End User (2027-2032)
6.3.3 World Single-Use Technology for Biopharmaceuticals Market Size Market Share by End User (2027-2032)
7 MARKET ANALYSIS BY SCALE OF OPERATION
7.1 World Single-Use Technology for Biopharmaceuticals Market Size Overview by Scale of Operation: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Scale of Operation
7.2.1 <50 L
7.2.2 50?500 L
7.2.3 500?1,000 L
7.2.4 >1,000 L
7.3 Market Segment by Scale of Operation
7.3.1 World Single-Use Technology for Biopharmaceuticals Market Size by Scale of Operation (2021-2026)
7.3.2 World Single-Use Technology for Biopharmaceuticals Market Size by Scale of Operation (2027-2032)
7.3.3 World Single-Use Technology for Biopharmaceuticals Market Size Market Share by Scale of Operation (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Single-Use Technology for Biopharmaceuticals Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Monoclonal Antibodies
8.2.2 Vaccines
8.2.3 Cell & Gene Therapy
8.2.4 Recombinant Proteins
8.2.5 Others
8.3 Market Segment by Application
8.3.1 World Single-Use Technology for Biopharmaceuticals Market Size by Application (2021-2026)
8.3.2 World Single-Use Technology for Biopharmaceuticals Market Size by Application (2027-2032)
8.3.3 World Single-Use Technology for Biopharmaceuticals Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Danaher (US)
9.1.1 Danaher (US) Details
9.1.2 Danaher (US) Major Business
9.1.3 Danaher (US) Single-Use Technology for Biopharmaceuticals Product and Services
9.1.4 Danaher (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Danaher (US) Recent Developments/Updates
9.1.6 Danaher (US) Competitive Strengths & Weaknesses
9.2 Sartorius (DE)
9.2.1 Sartorius (DE) Details
9.2.2 Sartorius (DE) Major Business
9.2.3 Sartorius (DE) Single-Use Technology for Biopharmaceuticals Product and Services
9.2.4 Sartorius (DE) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Sartorius (DE) Recent Developments/Updates
9.2.6 Sartorius (DE) Competitive Strengths & Weaknesses
9.3 Thermo Fisher Scientific (US)
9.3.1 Thermo Fisher Scientific (US) Details
9.3.2 Thermo Fisher Scientific (US) Major Business
9.3.3 Thermo Fisher Scientific (US) Single-Use Technology for Biopharmaceuticals Product and Services
9.3.4 Thermo Fisher Scientific (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Thermo Fisher Scientific (US) Recent Developments/Updates
9.3.6 Thermo Fisher Scientific (US) Competitive Strengths & Weaknesses
9.4 Merck KGaA (DE)
9.4.1 Merck KGaA (DE) Details
9.4.2 Merck KGaA (DE) Major Business
9.4.3 Merck KGaA (DE) Single-Use Technology for Biopharmaceuticals Product and Services
9.4.4 Merck KGaA (DE) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Merck KGaA (DE) Recent Developments/Updates
9.4.6 Merck KGaA (DE) Competitive Strengths & Weaknesses
9.5 Repligen (US)
9.5.1 Repligen (US) Details
9.5.2 Repligen (US) Major Business
9.5.3 Repligen (US) Single-Use Technology for Biopharmaceuticals Product and Services
9.5.4 Repligen (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Repligen (US) Recent Developments/Updates
9.5.6 Repligen (US) Competitive Strengths & Weaknesses
9.6 Meissner Filtration Products (US)
9.6.1 Meissner Filtration Products (US) Details
9.6.2 Meissner Filtration Products (US) Major Business
9.6.3 Meissner Filtration Products (US) Single-Use Technology for Biopharmaceuticals Product and Services
9.6.4 Meissner Filtration Products (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Meissner Filtration Products (US) Recent Developments/Updates
9.6.6 Meissner Filtration Products (US) Competitive Strengths & Weaknesses
9.7 ABEC (US)
9.7.1 ABEC (US) Details
9.7.2 ABEC (US) Major Business
9.7.3 ABEC (US) Single-Use Technology for Biopharmaceuticals Product and Services
9.7.4 ABEC (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 ABEC (US) Recent Developments/Updates
9.7.6 ABEC (US) Competitive Strengths & Weaknesses
9.8 Avantor (US)
9.8.1 Avantor (US) Details
9.8.2 Avantor (US) Major Business
9.8.3 Avantor (US) Single-Use Technology for Biopharmaceuticals Product and Services
9.8.4 Avantor (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Avantor (US) Recent Developments/Updates
9.8.6 Avantor (US) Competitive Strengths & Weaknesses
9.9 Corning (US)
9.9.1 Corning (US) Details
9.9.2 Corning (US) Major Business
9.9.3 Corning (US) Single-Use Technology for Biopharmaceuticals Product and Services
9.9.4 Corning (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Corning (US) Recent Developments/Updates
9.9.6 Corning (US) Competitive Strengths & Weaknesses
9.10 Entegris (US)
9.10.1 Entegris (US) Details
9.10.2 Entegris (US) Major Business
9.10.3 Entegris (US) Single-Use Technology for Biopharmaceuticals Product and Services
9.10.4 Entegris (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Entegris (US) Recent Developments/Updates
9.10.6 Entegris (US) Competitive Strengths & Weaknesses
9.11 Saint-Gobain Life Sciences (FR)
9.11.1 Saint-Gobain Life Sciences (FR) Details
9.11.2 Saint-Gobain Life Sciences (FR) Major Business
9.11.3 Saint-Gobain Life Sciences (FR) Single-Use Technology for Biopharmaceuticals Product and Services
9.11.4 Saint-Gobain Life Sciences (FR) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Saint-Gobain Life Sciences (FR) Recent Developments/Updates
9.11.6 Saint-Gobain Life Sciences (FR) Competitive Strengths & Weaknesses
9.12 Watson-Marlow / BioPure (GB)
9.12.1 Watson-Marlow / BioPure (GB) Details
9.12.2 Watson-Marlow / BioPure (GB) Major Business
9.12.3 Watson-Marlow / BioPure (GB) Single-Use Technology for Biopharmaceuticals Product and Services
9.12.4 Watson-Marlow / BioPure (GB) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Watson-Marlow / BioPure (GB) Recent Developments/Updates
9.12.6 Watson-Marlow / BioPure (GB) Competitive Strengths & Weaknesses
9.13 CPC / Colder Products (US)
9.13.1 CPC / Colder Products (US) Details
9.13.2 CPC / Colder Products (US) Major Business
9.13.3 CPC / Colder Products (US) Single-Use Technology for Biopharmaceuticals Product and Services
9.13.4 CPC / Colder Products (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 CPC / Colder Products (US) Recent Developments/Updates
9.13.6 CPC / Colder Products (US) Competitive Strengths & Weaknesses
9.14 Eppendorf (DE)
9.14.1 Eppendorf (DE) Details
9.14.2 Eppendorf (DE) Major Business
9.14.3 Eppendorf (DE) Single-Use Technology for Biopharmaceuticals Product and Services
9.14.4 Eppendorf (DE) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Eppendorf (DE) Recent Developments/Updates
9.14.6 Eppendorf (DE) Competitive Strengths & Weaknesses
9.15 Getinge / Applikon (SE)
9.15.1 Getinge / Applikon (SE) Details
9.15.2 Getinge / Applikon (SE) Major Business
9.15.3 Getinge / Applikon (SE) Single-Use Technology for Biopharmaceuticals Product and Services
9.15.4 Getinge / Applikon (SE) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Getinge / Applikon (SE) Recent Developments/Updates
9.15.6 Getinge / Applikon (SE) Competitive Strengths & Weaknesses
9.16 PBS Biotech (US)
9.16.1 PBS Biotech (US) Details
9.16.2 PBS Biotech (US) Major Business
9.16.3 PBS Biotech (US) Single-Use Technology for Biopharmaceuticals Product and Services
9.16.4 PBS Biotech (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 PBS Biotech (US) Recent Developments/Updates
9.16.6 PBS Biotech (US) Competitive Strengths & Weaknesses
9.17 Shanghai Tofflon Science and Technology Co., Ltd. (CN)
9.17.1 Shanghai Tofflon Science and Technology Co., Ltd. (CN) Details
9.17.2 Shanghai Tofflon Science and Technology Co., Ltd. (CN) Major Business
9.17.3 Shanghai Tofflon Science and Technology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Product and Services
9.17.4 Shanghai Tofflon Science and Technology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Shanghai Tofflon Science and Technology Co., Ltd. (CN) Recent Developments/Updates
9.17.6 Shanghai Tofflon Science and Technology Co., Ltd. (CN) Competitive Strengths & Weaknesses
9.18 Shanghai LePure Biotech Co., Ltd. (CN)
9.18.1 Shanghai LePure Biotech Co., Ltd. (CN) Details
9.18.2 Shanghai LePure Biotech Co., Ltd. (CN) Major Business
9.18.3 Shanghai LePure Biotech Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Product and Services
9.18.4 Shanghai LePure Biotech Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Shanghai LePure Biotech Co., Ltd. (CN) Recent Developments/Updates
9.18.6 Shanghai LePure Biotech Co., Ltd. (CN) Competitive Strengths & Weaknesses
9.19 Shanghai Duoning Biotechnology Co., Ltd. (CN)
9.19.1 Shanghai Duoning Biotechnology Co., Ltd. (CN) Details
9.19.2 Shanghai Duoning Biotechnology Co., Ltd. (CN) Major Business
9.19.3 Shanghai Duoning Biotechnology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Product and Services
9.19.4 Shanghai Duoning Biotechnology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Shanghai Duoning Biotechnology Co., Ltd. (CN) Recent Developments/Updates
9.19.6 Shanghai Duoning Biotechnology Co., Ltd. (CN) Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Single-Use Technology for Biopharmaceuticals Industry Chain
10.2 Single-Use Technology for Biopharmaceuticals Upstream Analysis
10.3 Single-Use Technology for Biopharmaceuticals Midstream Analysis
10.4 Single-Use Technology for Biopharmaceuticals Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Single-Use Technology for Biopharmaceuticals Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Single-Use Technology for Biopharmaceuticals Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Single-Use Technology for Biopharmaceuticals Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Single-Use Technology for Biopharmaceuticals Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Single-Use Technology for Biopharmaceuticals Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Single-Use Technology for Biopharmaceuticals Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Single-Use Technology for Biopharmaceuticals Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Single-Use Technology for Biopharmaceuticals Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Single-Use Technology for Biopharmaceuticals Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Single-Use Technology for Biopharmaceuticals Players in 2025
Table 12. World Single-Use Technology for Biopharmaceuticals Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Single-Use Technology for Biopharmaceuticals Company Evaluation Quadrant
Table 14. Head Office of Key Single-Use Technology for Biopharmaceuticals Players
Table 15. Single-Use Technology for Biopharmaceuticals Market: Company Product Type Footprint
Table 16. Single-Use Technology for Biopharmaceuticals Market: Company Product Application Footprint
Table 17. Single-Use Technology for Biopharmaceuticals Mergers & Acquisitions Activity
Table 18. United States VS China Single-Use Technology for Biopharmaceuticals Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Single-Use Technology for Biopharmaceuticals Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Single-Use Technology for Biopharmaceuticals Companies, Headquarters (States, Country)
Table 21. United States Based Companies Single-Use Technology for Biopharmaceuticals Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Single-Use Technology for Biopharmaceuticals Revenue Market Share (2021-2026)
Table 23. China Based Single-Use Technology for Biopharmaceuticals Companies, Headquarters (Province, Country)
Table 24. China Based Companies Single-Use Technology for Biopharmaceuticals Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Single-Use Technology for Biopharmaceuticals Revenue Market Share (2021-2026)
Table 26. Rest of World Based Single-Use Technology for Biopharmaceuticals Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Single-Use Technology for Biopharmaceuticals Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Single-Use Technology for Biopharmaceuticals Revenue Market Share (2021-2026)
Table 29. World Single-Use Technology for Biopharmaceuticals Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Single-Use Technology for Biopharmaceuticals Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Single-Use Technology for Biopharmaceuticals Market Size by Type (2027-2032) & (USD Million)
Table 32. World Single-Use Technology for Biopharmaceuticals Market Size by End User, (USD Million), 2021 & 2025 & 2032
Table 33. World Single-Use Technology for Biopharmaceuticals Market Size Value by End User (2021-2026) & (USD Million)
Table 34. World Single-Use Technology for Biopharmaceuticals Market Size by End User (2027-2032) & (USD Million)
Table 35. World Single-Use Technology for Biopharmaceuticals Market Size by Scale of Operation, (USD Million), 2021 & 2025 & 2032
Table 36. World Single-Use Technology for Biopharmaceuticals Market Size Value by Scale of Operation (2021-2026) & (USD Million)
Table 37. World Single-Use Technology for Biopharmaceuticals Market Size by Scale of Operation (2027-2032) & (USD Million)
Table 38. World Single-Use Technology for Biopharmaceuticals Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Single-Use Technology for Biopharmaceuticals Market Size by Application (2021-2026) & (USD Million)
Table 40. World Single-Use Technology for Biopharmaceuticals Market Size by Application (2027-2032) & (USD Million)
Table 41. Danaher (US) Basic Information, Manufacturing Base and Competitors
Table 42. Danaher (US) Major Business
Table 43. Danaher (US) Single-Use Technology for Biopharmaceuticals Product and Services
Table 44. Danaher (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Danaher (US) Recent Developments/Updates
Table 46. Danaher (US) Competitive Strengths & Weaknesses
Table 47. Sartorius (DE) Basic Information, Manufacturing Base and Competitors
Table 48. Sartorius (DE) Major Business
Table 49. Sartorius (DE) Single-Use Technology for Biopharmaceuticals Product and Services
Table 50. Sartorius (DE) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Sartorius (DE) Recent Developments/Updates
Table 52. Sartorius (DE) Competitive Strengths & Weaknesses
Table 53. Thermo Fisher Scientific (US) Basic Information, Manufacturing Base and Competitors
Table 54. Thermo Fisher Scientific (US) Major Business
Table 55. Thermo Fisher Scientific (US) Single-Use Technology for Biopharmaceuticals Product and Services
Table 56. Thermo Fisher Scientific (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Thermo Fisher Scientific (US) Recent Developments/Updates
Table 58. Thermo Fisher Scientific (US) Competitive Strengths & Weaknesses
Table 59. Merck KGaA (DE) Basic Information, Manufacturing Base and Competitors
Table 60. Merck KGaA (DE) Major Business
Table 61. Merck KGaA (DE) Single-Use Technology for Biopharmaceuticals Product and Services
Table 62. Merck KGaA (DE) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Merck KGaA (DE) Recent Developments/Updates
Table 64. Merck KGaA (DE) Competitive Strengths & Weaknesses
Table 65. Repligen (US) Basic Information, Manufacturing Base and Competitors
Table 66. Repligen (US) Major Business
Table 67. Repligen (US) Single-Use Technology for Biopharmaceuticals Product and Services
Table 68. Repligen (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Repligen (US) Recent Developments/Updates
Table 70. Repligen (US) Competitive Strengths & Weaknesses
Table 71. Meissner Filtration Products (US) Basic Information, Manufacturing Base and Competitors
Table 72. Meissner Filtration Products (US) Major Business
Table 73. Meissner Filtration Products (US) Single-Use Technology for Biopharmaceuticals Product and Services
Table 74. Meissner Filtration Products (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Meissner Filtration Products (US) Recent Developments/Updates
Table 76. Meissner Filtration Products (US) Competitive Strengths & Weaknesses
Table 77. ABEC (US) Basic Information, Manufacturing Base and Competitors
Table 78. ABEC (US) Major Business
Table 79. ABEC (US) Single-Use Technology for Biopharmaceuticals Product and Services
Table 80. ABEC (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. ABEC (US) Recent Developments/Updates
Table 82. ABEC (US) Competitive Strengths & Weaknesses
Table 83. Avantor (US) Basic Information, Manufacturing Base and Competitors
Table 84. Avantor (US) Major Business
Table 85. Avantor (US) Single-Use Technology for Biopharmaceuticals Product and Services
Table 86. Avantor (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Avantor (US) Recent Developments/Updates
Table 88. Avantor (US) Competitive Strengths & Weaknesses
Table 89. Corning (US) Basic Information, Manufacturing Base and Competitors
Table 90. Corning (US) Major Business
Table 91. Corning (US) Single-Use Technology for Biopharmaceuticals Product and Services
Table 92. Corning (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Corning (US) Recent Developments/Updates
Table 94. Corning (US) Competitive Strengths & Weaknesses
Table 95. Entegris (US) Basic Information, Manufacturing Base and Competitors
Table 96. Entegris (US) Major Business
Table 97. Entegris (US) Single-Use Technology for Biopharmaceuticals Product and Services
Table 98. Entegris (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Entegris (US) Recent Developments/Updates
Table 100. Entegris (US) Competitive Strengths & Weaknesses
Table 101. Saint-Gobain Life Sciences (FR) Basic Information, Manufacturing Base and Competitors
Table 102. Saint-Gobain Life Sciences (FR) Major Business
Table 103. Saint-Gobain Life Sciences (FR) Single-Use Technology for Biopharmaceuticals Product and Services
Table 104. Saint-Gobain Life Sciences (FR) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Saint-Gobain Life Sciences (FR) Recent Developments/Updates
Table 106. Saint-Gobain Life Sciences (FR) Competitive Strengths & Weaknesses
Table 107. Watson-Marlow / BioPure (GB) Basic Information, Manufacturing Base and Competitors
Table 108. Watson-Marlow / BioPure (GB) Major Business
Table 109. Watson-Marlow / BioPure (GB) Single-Use Technology for Biopharmaceuticals Product and Services
Table 110. Watson-Marlow / BioPure (GB) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Watson-Marlow / BioPure (GB) Recent Developments/Updates
Table 112. Watson-Marlow / BioPure (GB) Competitive Strengths & Weaknesses
Table 113. CPC / Colder Products (US) Basic Information, Manufacturing Base and Competitors
Table 114. CPC / Colder Products (US) Major Business
Table 115. CPC / Colder Products (US) Single-Use Technology for Biopharmaceuticals Product and Services
Table 116. CPC / Colder Products (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. CPC / Colder Products (US) Recent Developments/Updates
Table 118. CPC / Colder Products (US) Competitive Strengths & Weaknesses
Table 119. Eppendorf (DE) Basic Information, Manufacturing Base and Competitors
Table 120. Eppendorf (DE) Major Business
Table 121. Eppendorf (DE) Single-Use Technology for Biopharmaceuticals Product and Services
Table 122. Eppendorf (DE) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Eppendorf (DE) Recent Developments/Updates
Table 124. Eppendorf (DE) Competitive Strengths & Weaknesses
Table 125. Getinge / Applikon (SE) Basic Information, Manufacturing Base and Competitors
Table 126. Getinge / Applikon (SE) Major Business
Table 127. Getinge / Applikon (SE) Single-Use Technology for Biopharmaceuticals Product and Services
Table 128. Getinge / Applikon (SE) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Getinge / Applikon (SE) Recent Developments/Updates
Table 130. Getinge / Applikon (SE) Competitive Strengths & Weaknesses
Table 131. PBS Biotech (US) Basic Information, Manufacturing Base and Competitors
Table 132. PBS Biotech (US) Major Business
Table 133. PBS Biotech (US) Single-Use Technology for Biopharmaceuticals Product and Services
Table 134. PBS Biotech (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. PBS Biotech (US) Recent Developments/Updates
Table 136. PBS Biotech (US) Competitive Strengths & Weaknesses
Table 137. Shanghai Tofflon Science and Technology Co., Ltd. (CN) Basic Information, Manufacturing Base and Competitors
Table 138. Shanghai Tofflon Science and Technology Co., Ltd. (CN) Major Business
Table 139. Shanghai Tofflon Science and Technology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Product and Services
Table 140. Shanghai Tofflon Science and Technology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Shanghai Tofflon Science and Technology Co., Ltd. (CN) Recent Developments/Updates
Table 142. Shanghai Tofflon Science and Technology Co., Ltd. (CN) Competitive Strengths & Weaknesses
Table 143. Shanghai LePure Biotech Co., Ltd. (CN) Basic Information, Manufacturing Base and Competitors
Table 144. Shanghai LePure Biotech Co., Ltd. (CN) Major Business
Table 145. Shanghai LePure Biotech Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Product and Services
Table 146. Shanghai LePure Biotech Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Shanghai LePure Biotech Co., Ltd. (CN) Recent Developments/Updates
Table 148. Shanghai LePure Biotech Co., Ltd. (CN) Competitive Strengths & Weaknesses
Table 149. Shanghai Duoning Biotechnology Co., Ltd. (CN) Basic Information, Manufacturing Base and Competitors
Table 150. Shanghai Duoning Biotechnology Co., Ltd. (CN) Major Business
Table 151. Shanghai Duoning Biotechnology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Product and Services
Table 152. Shanghai Duoning Biotechnology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Shanghai Duoning Biotechnology Co., Ltd. (CN) Recent Developments/Updates
Table 154. Shanghai Duoning Biotechnology Co., Ltd. (CN) Competitive Strengths & Weaknesses
Table 155. Global Key Players of Single-Use Technology for Biopharmaceuticals Upstream (Raw Materials)
Table 156. Global Single-Use Technology for Biopharmaceuticals Typical Customers
Table 1. World Single-Use Technology for Biopharmaceuticals Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Single-Use Technology for Biopharmaceuticals Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Single-Use Technology for Biopharmaceuticals Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Single-Use Technology for Biopharmaceuticals Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Single-Use Technology for Biopharmaceuticals Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Single-Use Technology for Biopharmaceuticals Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Single-Use Technology for Biopharmaceuticals Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Single-Use Technology for Biopharmaceuticals Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Single-Use Technology for Biopharmaceuticals Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Single-Use Technology for Biopharmaceuticals Players in 2025
Table 12. World Single-Use Technology for Biopharmaceuticals Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Single-Use Technology for Biopharmaceuticals Company Evaluation Quadrant
Table 14. Head Office of Key Single-Use Technology for Biopharmaceuticals Players
Table 15. Single-Use Technology for Biopharmaceuticals Market: Company Product Type Footprint
Table 16. Single-Use Technology for Biopharmaceuticals Market: Company Product Application Footprint
Table 17. Single-Use Technology for Biopharmaceuticals Mergers & Acquisitions Activity
Table 18. United States VS China Single-Use Technology for Biopharmaceuticals Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Single-Use Technology for Biopharmaceuticals Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Single-Use Technology for Biopharmaceuticals Companies, Headquarters (States, Country)
Table 21. United States Based Companies Single-Use Technology for Biopharmaceuticals Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Single-Use Technology for Biopharmaceuticals Revenue Market Share (2021-2026)
Table 23. China Based Single-Use Technology for Biopharmaceuticals Companies, Headquarters (Province, Country)
Table 24. China Based Companies Single-Use Technology for Biopharmaceuticals Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Single-Use Technology for Biopharmaceuticals Revenue Market Share (2021-2026)
Table 26. Rest of World Based Single-Use Technology for Biopharmaceuticals Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Single-Use Technology for Biopharmaceuticals Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Single-Use Technology for Biopharmaceuticals Revenue Market Share (2021-2026)
Table 29. World Single-Use Technology for Biopharmaceuticals Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Single-Use Technology for Biopharmaceuticals Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Single-Use Technology for Biopharmaceuticals Market Size by Type (2027-2032) & (USD Million)
Table 32. World Single-Use Technology for Biopharmaceuticals Market Size by End User, (USD Million), 2021 & 2025 & 2032
Table 33. World Single-Use Technology for Biopharmaceuticals Market Size Value by End User (2021-2026) & (USD Million)
Table 34. World Single-Use Technology for Biopharmaceuticals Market Size by End User (2027-2032) & (USD Million)
Table 35. World Single-Use Technology for Biopharmaceuticals Market Size by Scale of Operation, (USD Million), 2021 & 2025 & 2032
Table 36. World Single-Use Technology for Biopharmaceuticals Market Size Value by Scale of Operation (2021-2026) & (USD Million)
Table 37. World Single-Use Technology for Biopharmaceuticals Market Size by Scale of Operation (2027-2032) & (USD Million)
Table 38. World Single-Use Technology for Biopharmaceuticals Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Single-Use Technology for Biopharmaceuticals Market Size by Application (2021-2026) & (USD Million)
Table 40. World Single-Use Technology for Biopharmaceuticals Market Size by Application (2027-2032) & (USD Million)
Table 41. Danaher (US) Basic Information, Manufacturing Base and Competitors
Table 42. Danaher (US) Major Business
Table 43. Danaher (US) Single-Use Technology for Biopharmaceuticals Product and Services
Table 44. Danaher (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Danaher (US) Recent Developments/Updates
Table 46. Danaher (US) Competitive Strengths & Weaknesses
Table 47. Sartorius (DE) Basic Information, Manufacturing Base and Competitors
Table 48. Sartorius (DE) Major Business
Table 49. Sartorius (DE) Single-Use Technology for Biopharmaceuticals Product and Services
Table 50. Sartorius (DE) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Sartorius (DE) Recent Developments/Updates
Table 52. Sartorius (DE) Competitive Strengths & Weaknesses
Table 53. Thermo Fisher Scientific (US) Basic Information, Manufacturing Base and Competitors
Table 54. Thermo Fisher Scientific (US) Major Business
Table 55. Thermo Fisher Scientific (US) Single-Use Technology for Biopharmaceuticals Product and Services
Table 56. Thermo Fisher Scientific (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Thermo Fisher Scientific (US) Recent Developments/Updates
Table 58. Thermo Fisher Scientific (US) Competitive Strengths & Weaknesses
Table 59. Merck KGaA (DE) Basic Information, Manufacturing Base and Competitors
Table 60. Merck KGaA (DE) Major Business
Table 61. Merck KGaA (DE) Single-Use Technology for Biopharmaceuticals Product and Services
Table 62. Merck KGaA (DE) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Merck KGaA (DE) Recent Developments/Updates
Table 64. Merck KGaA (DE) Competitive Strengths & Weaknesses
Table 65. Repligen (US) Basic Information, Manufacturing Base and Competitors
Table 66. Repligen (US) Major Business
Table 67. Repligen (US) Single-Use Technology for Biopharmaceuticals Product and Services
Table 68. Repligen (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Repligen (US) Recent Developments/Updates
Table 70. Repligen (US) Competitive Strengths & Weaknesses
Table 71. Meissner Filtration Products (US) Basic Information, Manufacturing Base and Competitors
Table 72. Meissner Filtration Products (US) Major Business
Table 73. Meissner Filtration Products (US) Single-Use Technology for Biopharmaceuticals Product and Services
Table 74. Meissner Filtration Products (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Meissner Filtration Products (US) Recent Developments/Updates
Table 76. Meissner Filtration Products (US) Competitive Strengths & Weaknesses
Table 77. ABEC (US) Basic Information, Manufacturing Base and Competitors
Table 78. ABEC (US) Major Business
Table 79. ABEC (US) Single-Use Technology for Biopharmaceuticals Product and Services
Table 80. ABEC (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. ABEC (US) Recent Developments/Updates
Table 82. ABEC (US) Competitive Strengths & Weaknesses
Table 83. Avantor (US) Basic Information, Manufacturing Base and Competitors
Table 84. Avantor (US) Major Business
Table 85. Avantor (US) Single-Use Technology for Biopharmaceuticals Product and Services
Table 86. Avantor (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Avantor (US) Recent Developments/Updates
Table 88. Avantor (US) Competitive Strengths & Weaknesses
Table 89. Corning (US) Basic Information, Manufacturing Base and Competitors
Table 90. Corning (US) Major Business
Table 91. Corning (US) Single-Use Technology for Biopharmaceuticals Product and Services
Table 92. Corning (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Corning (US) Recent Developments/Updates
Table 94. Corning (US) Competitive Strengths & Weaknesses
Table 95. Entegris (US) Basic Information, Manufacturing Base and Competitors
Table 96. Entegris (US) Major Business
Table 97. Entegris (US) Single-Use Technology for Biopharmaceuticals Product and Services
Table 98. Entegris (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Entegris (US) Recent Developments/Updates
Table 100. Entegris (US) Competitive Strengths & Weaknesses
Table 101. Saint-Gobain Life Sciences (FR) Basic Information, Manufacturing Base and Competitors
Table 102. Saint-Gobain Life Sciences (FR) Major Business
Table 103. Saint-Gobain Life Sciences (FR) Single-Use Technology for Biopharmaceuticals Product and Services
Table 104. Saint-Gobain Life Sciences (FR) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Saint-Gobain Life Sciences (FR) Recent Developments/Updates
Table 106. Saint-Gobain Life Sciences (FR) Competitive Strengths & Weaknesses
Table 107. Watson-Marlow / BioPure (GB) Basic Information, Manufacturing Base and Competitors
Table 108. Watson-Marlow / BioPure (GB) Major Business
Table 109. Watson-Marlow / BioPure (GB) Single-Use Technology for Biopharmaceuticals Product and Services
Table 110. Watson-Marlow / BioPure (GB) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Watson-Marlow / BioPure (GB) Recent Developments/Updates
Table 112. Watson-Marlow / BioPure (GB) Competitive Strengths & Weaknesses
Table 113. CPC / Colder Products (US) Basic Information, Manufacturing Base and Competitors
Table 114. CPC / Colder Products (US) Major Business
Table 115. CPC / Colder Products (US) Single-Use Technology for Biopharmaceuticals Product and Services
Table 116. CPC / Colder Products (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. CPC / Colder Products (US) Recent Developments/Updates
Table 118. CPC / Colder Products (US) Competitive Strengths & Weaknesses
Table 119. Eppendorf (DE) Basic Information, Manufacturing Base and Competitors
Table 120. Eppendorf (DE) Major Business
Table 121. Eppendorf (DE) Single-Use Technology for Biopharmaceuticals Product and Services
Table 122. Eppendorf (DE) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Eppendorf (DE) Recent Developments/Updates
Table 124. Eppendorf (DE) Competitive Strengths & Weaknesses
Table 125. Getinge / Applikon (SE) Basic Information, Manufacturing Base and Competitors
Table 126. Getinge / Applikon (SE) Major Business
Table 127. Getinge / Applikon (SE) Single-Use Technology for Biopharmaceuticals Product and Services
Table 128. Getinge / Applikon (SE) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Getinge / Applikon (SE) Recent Developments/Updates
Table 130. Getinge / Applikon (SE) Competitive Strengths & Weaknesses
Table 131. PBS Biotech (US) Basic Information, Manufacturing Base and Competitors
Table 132. PBS Biotech (US) Major Business
Table 133. PBS Biotech (US) Single-Use Technology for Biopharmaceuticals Product and Services
Table 134. PBS Biotech (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. PBS Biotech (US) Recent Developments/Updates
Table 136. PBS Biotech (US) Competitive Strengths & Weaknesses
Table 137. Shanghai Tofflon Science and Technology Co., Ltd. (CN) Basic Information, Manufacturing Base and Competitors
Table 138. Shanghai Tofflon Science and Technology Co., Ltd. (CN) Major Business
Table 139. Shanghai Tofflon Science and Technology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Product and Services
Table 140. Shanghai Tofflon Science and Technology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Shanghai Tofflon Science and Technology Co., Ltd. (CN) Recent Developments/Updates
Table 142. Shanghai Tofflon Science and Technology Co., Ltd. (CN) Competitive Strengths & Weaknesses
Table 143. Shanghai LePure Biotech Co., Ltd. (CN) Basic Information, Manufacturing Base and Competitors
Table 144. Shanghai LePure Biotech Co., Ltd. (CN) Major Business
Table 145. Shanghai LePure Biotech Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Product and Services
Table 146. Shanghai LePure Biotech Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Shanghai LePure Biotech Co., Ltd. (CN) Recent Developments/Updates
Table 148. Shanghai LePure Biotech Co., Ltd. (CN) Competitive Strengths & Weaknesses
Table 149. Shanghai Duoning Biotechnology Co., Ltd. (CN) Basic Information, Manufacturing Base and Competitors
Table 150. Shanghai Duoning Biotechnology Co., Ltd. (CN) Major Business
Table 151. Shanghai Duoning Biotechnology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Product and Services
Table 152. Shanghai Duoning Biotechnology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Shanghai Duoning Biotechnology Co., Ltd. (CN) Recent Developments/Updates
Table 154. Shanghai Duoning Biotechnology Co., Ltd. (CN) Competitive Strengths & Weaknesses
Table 155. Global Key Players of Single-Use Technology for Biopharmaceuticals Upstream (Raw Materials)
Table 156. Global Single-Use Technology for Biopharmaceuticals Typical Customers
LIST OF FIGURES
Figure 1. Single-Use Technology for Biopharmaceuticals Picture
Figure 2. World Single-Use Technology for Biopharmaceuticals Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Single-Use Technology for Biopharmaceuticals Total Revenue (2021-2032) & (USD Million)
Figure 4. World Single-Use Technology for Biopharmaceuticals Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Single-Use Technology for Biopharmaceuticals Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Single-Use Technology for Biopharmaceuticals Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Single-Use Technology for Biopharmaceuticals Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Single-Use Technology for Biopharmaceuticals Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Single-Use Technology for Biopharmaceuticals Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Single-Use Technology for Biopharmaceuticals Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Single-Use Technology for Biopharmaceuticals Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Single-Use Technology for Biopharmaceuticals Revenue (2021-2032) & (USD Million)
Figure 13. Single-Use Technology for Biopharmaceuticals Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 16. World Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 18. China Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 23. India Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Single-Use Technology for Biopharmaceuticals by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Single-Use Technology for Biopharmaceuticals Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Single-Use Technology for Biopharmaceuticals Markets in 2025
Figure 27. United States VS China: Single-Use Technology for Biopharmaceuticals Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Single-Use Technology for Biopharmaceuticals Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Single-Use Technology for Biopharmaceuticals Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Single-Use Technology for Biopharmaceuticals Market Size Market Share by Type in 2025
Figure 31. Single-use Bioreactors
Figure 32. Single-use Bags & Containers
Figure 33. Filtration Assemblies
Figure 34. Tubing & Connectors
Figure 35. Others
Figure 36. World Single-Use Technology for Biopharmaceuticals Market Size Market Share by Type (2021-2032)
Figure 37. World Single-Use Technology for Biopharmaceuticals Market Size by End User, (USD Million), 2021 & 2025 & 2032
Figure 38. World Single-Use Technology for Biopharmaceuticals Market Size Market Share by End User in 2025
Figure 39. Biopharmaceutical Companies
Figure 40. CDMOs / CMOs
Figure 41. Research Institutes
Figure 42. Cell & Gene Therapy Companies
Figure 43. Vaccine Manufacturers
Figure 44. World Single-Use Technology for Biopharmaceuticals Market Size Market Share by End User (2021-2032)
Figure 45. World Single-Use Technology for Biopharmaceuticals Market Size by Scale of Operation, (USD Million), 2021 & 2025 & 2032
Figure 46. World Single-Use Technology for Biopharmaceuticals Market Size Market Share by Scale of Operation in 2025
Figure 47. <50 L
Figure 48. 50?500 L
Figure 49. 500?1,000 L
Figure 50. >1,000 L
Figure 51. World Single-Use Technology for Biopharmaceuticals Market Size Market Share by Scale of Operation (2021-2032)
Figure 52. World Single-Use Technology for Biopharmaceuticals Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 53. World Single-Use Technology for Biopharmaceuticals Market Size Market Share by Application in 2025
Figure 54. Monoclonal Antibodies
Figure 55. Vaccines
Figure 56. Cell & Gene Therapy
Figure 57. Recombinant Proteins
Figure 58. Others
Figure 59. World Single-Use Technology for Biopharmaceuticals Market Size Market Share by Application (2021-2032)
Figure 60. Single-Use Technology for Biopharmaceuticals Industrial Chain
Figure 61. Methodology
Figure 62. Research Process and Data Source
Figure 1. Single-Use Technology for Biopharmaceuticals Picture
Figure 2. World Single-Use Technology for Biopharmaceuticals Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Single-Use Technology for Biopharmaceuticals Total Revenue (2021-2032) & (USD Million)
Figure 4. World Single-Use Technology for Biopharmaceuticals Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Single-Use Technology for Biopharmaceuticals Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Single-Use Technology for Biopharmaceuticals Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Single-Use Technology for Biopharmaceuticals Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Single-Use Technology for Biopharmaceuticals Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Single-Use Technology for Biopharmaceuticals Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Single-Use Technology for Biopharmaceuticals Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Single-Use Technology for Biopharmaceuticals Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Single-Use Technology for Biopharmaceuticals Revenue (2021-2032) & (USD Million)
Figure 13. Single-Use Technology for Biopharmaceuticals Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 16. World Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 18. China Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 23. India Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Single-Use Technology for Biopharmaceuticals by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Single-Use Technology for Biopharmaceuticals Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Single-Use Technology for Biopharmaceuticals Markets in 2025
Figure 27. United States VS China: Single-Use Technology for Biopharmaceuticals Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Single-Use Technology for Biopharmaceuticals Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Single-Use Technology for Biopharmaceuticals Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Single-Use Technology for Biopharmaceuticals Market Size Market Share by Type in 2025
Figure 31. Single-use Bioreactors
Figure 32. Single-use Bags & Containers
Figure 33. Filtration Assemblies
Figure 34. Tubing & Connectors
Figure 35. Others
Figure 36. World Single-Use Technology for Biopharmaceuticals Market Size Market Share by Type (2021-2032)
Figure 37. World Single-Use Technology for Biopharmaceuticals Market Size by End User, (USD Million), 2021 & 2025 & 2032
Figure 38. World Single-Use Technology for Biopharmaceuticals Market Size Market Share by End User in 2025
Figure 39. Biopharmaceutical Companies
Figure 40. CDMOs / CMOs
Figure 41. Research Institutes
Figure 42. Cell & Gene Therapy Companies
Figure 43. Vaccine Manufacturers
Figure 44. World Single-Use Technology for Biopharmaceuticals Market Size Market Share by End User (2021-2032)
Figure 45. World Single-Use Technology for Biopharmaceuticals Market Size by Scale of Operation, (USD Million), 2021 & 2025 & 2032
Figure 46. World Single-Use Technology for Biopharmaceuticals Market Size Market Share by Scale of Operation in 2025
Figure 47. <50 L
Figure 48. 50?500 L
Figure 49. 500?1,000 L
Figure 50. >1,000 L
Figure 51. World Single-Use Technology for Biopharmaceuticals Market Size Market Share by Scale of Operation (2021-2032)
Figure 52. World Single-Use Technology for Biopharmaceuticals Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 53. World Single-Use Technology for Biopharmaceuticals Market Size Market Share by Application in 2025
Figure 54. Monoclonal Antibodies
Figure 55. Vaccines
Figure 56. Cell & Gene Therapy
Figure 57. Recombinant Proteins
Figure 58. Others
Figure 59. World Single-Use Technology for Biopharmaceuticals Market Size Market Share by Application (2021-2032)
Figure 60. Single-Use Technology for Biopharmaceuticals Industrial Chain
Figure 61. Methodology
Figure 62. Research Process and Data Source
